UPSHER-SMITH RECEIVES TENTATIVE NDA APPROVAL FOR VOGELXO (TESTOSTERONE) GEL CII
ENP Newswire - 20 August 2013
Release date- 16082013 - Maple Grove, MN - Upsher-Smith Laboratories, Inc., today announced that ithas received tentative approval from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for Vogelxo (testosterone) gel for topical use CIII.
[Editorial queries for this story should be sent to email@example.com]
((Comments on this story may be sent to firstname.lastname@example.org))